{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:33:12Z","timestamp":1767979992635,"version":"3.49.0"},"reference-count":100,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>While research on high-incidence tumors such as breast, prostate, and lung cancer has led to significant increases in patient survival in recent years, this has not been the case for low-incidence tumors such as high-grade gliomas, the most common and lethal brain tumors, for which the last significant therapeutic advance dates back to 2005. The high infiltration capacity of these tumors into normal brain tissue essential for both vegetative and relational life, the tumor microenvironment, with poor immunological activity, the multiple resistance mechanisms, and the unattractiveness of research investments due to the limited number of patients have made, and continue to make, the path to achieving significant improvements in the survival of patients with high-grade gliomas long and arduous. The objective of this article is to update the slow but continuous radiotherapeutic progress for adult and pediatric high-grade gliomas to the second half of 2023. We analyzed the progress of preclinical and clinical research on both adult and pediatric high-grade gliomas, with a particular focus on improvements in radiotherapy. Interactions between non-radiant new therapies and radiotherapy were also covered. A literature search was conducted in PubMed using the terms (\u201cglioma* and radio*\u201d) and the time limit of 1 July 2023 to 31 December 2023. The inclusion and exclusion criteria for the review were relevance to advances in radiotherapy for high-grade gliomas in adults and children. Treating patients with advanced disease progression only, using \u201chistorical\u201d data as controls, as well as repurposing drugs developed for purposes completely different from their intended use, were the major (but not the only) methods to assess risk of bias in the included studies. The effect measures used in the synthesis or presentation of the results were tabulated and\/or displayed in figures. A total of 100 relevant references were reviewed. Advances in preclinical studies and in clinical radiotherapy treatment planning, innovative fractionation, use of radioisotopes\/radiopharmaceuticals, radiosensitization procedures, and radiation-induced damage were focused on. While this analysis may be limited by the relatively short publication period, high-grade glioma research remains impacted, especially at the clinical level, by potential issues with trial design, such as treating patients with advanced disease progression, using \u201chistorical\u201d data as controls, and repurposing drugs developed for completely different purposes than intended. Addressing these aspects of high-grade glioma research could improve its efficacy, which often remains low despite the associated costs.<\/jats:p>","DOI":"10.3390\/ijms27020662","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:25:02Z","timestamp":1767950702000},"page":"662","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy for High-Grade Gliomas in Adults and Children: A Systematic Review of Advances Published in the Second Half of 2023"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6717-5097","authenticated-orcid":false,"given":"Guido","family":"Frosina","sequence":"first","affiliation":[{"name":"Neuro-Oncology & Mutagenesis Unit, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.32074\/1591-951X-823","article-title":"Adult Type Diffuse Gliomas in the New 2021 WHO Classification","volume":"114","author":"Antonelli","year":"2022","journal-title":"Pathologica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"123058","DOI":"10.1016\/j.jns.2024.123058","article-title":"Glial and Glioneuronal Tumors: Navigating the Complexity of Evolving Concepts and New Classification","volume":"461","author":"Han","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00062-023-01277-z","article-title":"Adult-Type and Pediatric-Type Diffuse Gliomas: What the Neuroradiologist should Know","volume":"33","author":"Nafe","year":"2023","journal-title":"Clin. Neuroradiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-023-02654-1","article-title":"\u201cDe Novo Replication Repair Deficient Glioblastoma, IDH-Wildtype\u201d is a Distinct Glioblastoma Subtype in Adults that may Benefit from Immune Checkpoint Blockade","volume":"147","author":"Hadad","year":"2023","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/neuonc\/noad035","article-title":"Molecular Changes Underlying Decay of Sensory Responses and Enhanced Seizure Propensity in Peritumoral Neurons","volume":"25","author":"Tantillo","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary Brain Tumours in Adults","volume":"402","author":"Geurts","year":"2023","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104110","DOI":"10.1016\/j.critrevonc.2023.104110","article-title":"Radiotherapy of High-Grade Gliomas: Dealing with a Stalemate","volume":"190","author":"Frosina","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20604","DOI":"10.1038\/s41598-023-47552-4","article-title":"Efficacy of Combined Tumor Irradiation and K(Ca)3.1-Targeting with TRAM-34 in a Syngeneic Glioma Mouse Model","volume":"13","author":"Stransky","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/or.2023.8681","article-title":"Inhibitor of Wnt Receptor 1 Suppresses the Effects of Wnt1, Wnt3a and \u0392-catenin on the Proliferation and Migration of C6 GSCs Induced by Low-dose Radiation","volume":"51","author":"Yan","year":"2024","journal-title":"Oncol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41419-023-06282-1","article-title":"Ferroptosis Sensitization in Glioma: Exploring the Regulatory Mechanism of SOAT1 and its Therapeutic Implications","volume":"14","author":"Sun","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16432","DOI":"10.1021\/acsnano.2c12857","article-title":"Engineered Extracellular Vesicle-Delivered CRISPR\/Cas9 for Radiotherapy Sensitization of Glioblastoma","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tran, N.H., Ryzhov, V., Volnitskiy, A., Amerkanov, D., Pack, F., Golubev, A.M., Arutyunyan, A., Spitsyna, A., Burdakov, V., and Lebedev, D. (2023). Radiosensitizing Effect of Dextran-Coated Iron Oxide Nanoparticles on Malignant Glioma Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015150"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41419-023-05933-7","article-title":"METTL3-Mediated m6A Modification of LINC00839 Maintains Glioma Stem Cells and Radiation Resistance by Activating Wnt\/\u0392-Catenin Signaling","volume":"14","author":"Yin","year":"2023","journal-title":"Cell. Death Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/neuonc\/noad210","article-title":"Inhibition of ATR Opposes Glioblastoma Invasion through Disruption of Cytoskeletal Networks and Integrin Internali-sation Via Macropinocytosis","volume":"26","author":"Derby","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rochette, L., Dogon, G., Zeller, M., Cottin, Y., and Vergely, C. (2023). Antitumoral Activity of Molecular Hydrogen and Proton in the Treatment of Glioblastoma: An Atypical Pharmacology?. Brain Sci., 13.","DOI":"10.3390\/brainsci13081168"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/neuonc\/noad103","article-title":"M2 Isoform of Pyruvate Kinase Rewires Glucose Metabolism during Radiation Therapy to Promote an Antioxidant Response and Glioblastoma Radioresistance","volume":"25","author":"Bailleul","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2234101","DOI":"10.1080\/08916934.2023.2234101","article-title":"DNA Polymerase \u0396 Suppresses the Radiosensitivity of Glioma Cells by Regulating the PI3K\/AKT\/mTOR Pathway","volume":"56","author":"Ding","year":"2023","journal-title":"Autoimmunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3892\/etm.2023.12059","article-title":"5-aminiolevulinic Acid Induces a Radiodynamic Effect with Enhanced Delayed Reactive Oxygen Species Production Under Hypoxic Conditions in Lymphoma Cells: An in Vitro Study","volume":"26","author":"Suzuki","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5603\/RPOR.a2023.0034","article-title":"Re-Irradiation with Stereotactic Radiotherapy for Recurrent High-Grade Glial Tumors","volume":"28","author":"Soykut","year":"2023","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e14162","DOI":"10.1002\/acm2.14162","article-title":"The Influence of Patient Positioning and Immobilization Equipment on MR Image Quality and Image Registration in Radiation Therapy","volume":"25","author":"Rostami","year":"2023","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"175035","DOI":"10.1088\/1361-6560\/acf023","article-title":"Geometric Evaluations of CT and MRI Based Deep Learning Segmentation for Brain OARs in Radiotherapy","volume":"68","author":"Alzahrani","year":"2023","journal-title":"Phys. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e14197","DOI":"10.1002\/acm2.14197","article-title":"Deep-Neural Network Approaches for Predicting 3D Dose Distribution in Intensity-Modulated Radiotherapy of the Brain Tumors","volume":"25","author":"Irannejad","year":"2023","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e14044","DOI":"10.1002\/acm2.14044","article-title":"Clinical Feasibility of a Commercially Available MRI-Only Method for Radiotherapy Treatment Planning of the Brain","volume":"24","author":"Ranta","year":"2023","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102669","DOI":"10.1016\/j.ejmp.2023.102669","article-title":"Overall Survival Prediction for High-Grade Glioma Patients using Mathematical Modeling of Tumor Cell Infiltration","volume":"113","author":"Astaraki","year":"2023","journal-title":"Phys. Med."},{"key":"ref_26","first-page":"vdad171","article-title":"Toward Image-Based Personalization of Glioblastoma Therapy: A Clinical and Biological Validation Study of a Novel, Deep Learning-Driven Tumor Growth Model","volume":"6","author":"Metz","year":"2023","journal-title":"Neurooncol. Adv."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Thompson, C., Pagett, C., Lilley, J., Svensson, S., Eriksson, K., Bokrantz, R., \u00d6d\u00e9n, J., Nix, M., Murray, L., and Appelt, A. (2023). Brain Re-Irradiation Robustly Accounting for Previously Delivered Dose. Cancers, 15.","DOI":"10.3390\/cancers15153831"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19659","DOI":"10.1038\/s41598-023-46335-1","article-title":"IDH1(R132H) Mutation Increases Radiotherapy Efficacy and a 4-Gene Radiotherapy-Related Signature of WHO Grade 4 Gliomas","volume":"13","author":"Han","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kim, N., Shin, H., Lim, D.H., Nam, D., Lee, J., Seol, H.J., Kong, D., Choi, J.W., Chong, K., and Lee, W.J. (2023). Treatment Outcomes After Dose-Escalated Moderately Hypofractionated Radiotherapy for Frail Patients with High-Grade Glioma. Cancers, 16.","DOI":"10.3390\/cancers16010064"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.clon.2023.07.001","article-title":"Short-Course Palliative Hypofractionated Radiotherapy in Patients with Poor-Prognosis High-Grade Glioma: Survival and Quality of Life Outcomes from a Prospective Phase II Study","volume":"35","author":"Baviskar","year":"2023","journal-title":"Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00066-023-02172-9","article-title":"Reirradiation with Radiosurgery Or Stereotactic Fractionated Radiotherapy in Association with Regorafenib in Recur-rent Glioblastoma","volume":"200","author":"Gregucci","year":"2023","journal-title":"Strahlenther. Onkol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2023.09.014","article-title":"Intraoperative Radiotherapy After Resection of Brain Metastases Located in the Posterior Fossa. Analysis of Postoperative Morbidity and Mortality in a Single Center Cohort","volume":"118","author":"Krauss","year":"2023","journal-title":"J. Clin. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45713","DOI":"10.1021\/acsami.3c11098","article-title":"Multimodal Imaging-Guided Strategy for Developing (177)Lu-Labeled Metal-Organic Framework Nanomedicine with Potential in Cancer Therapy","volume":"15","author":"Liang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Krauze, A.V., Zhao, Y., Li, M., Shih, J., Jiang, W., Tasci, E., Cooley Zgela, T., Sproull, M., Mackey, M., and Shankavaram, U. (2023). Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation. Biomolecules, 13.","DOI":"10.3390\/biom13101499"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1667\/RADE-22-00198","article-title":"Effect of Temozolomide Combined with Intensity Modulated Radiation Therapy on Serum Factor, Immune Function and Clinical Efficacy in Postoperative Glioma Patients","volume":"200","author":"Yuan","year":"2023","journal-title":"Radiat. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Annakib, S., Rigau, V., Darlix, A., Goz\u00e9, C., Duffau, H., Bauchet, L., Jarlier, M., and Fabbro, M. (2023). Bevacizumab in Recurrent WHO Grades II-III Glioma. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1212714"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11060-023-04397-1","article-title":"Significance of O6-Methyl Guanine Methyltransferase Promoter Methylation in High Grade Glioma Patients: Optimal Cutoff Point, CpG Locus, and Genetic Assay","volume":"164","author":"Buyuktepe","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_38","first-page":"7781","article-title":"The Prognosis of Gliomas with Different Molecular Subtypes in the Era of Intensity-Modulated Radiation Therapy (IMRT)","volume":"15","author":"Zhong","year":"2023","journal-title":"Aging"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ghanem, P., Fatteh, M., Kamson, D.O., Balan, A., Chang, M., Tao, J., Blakeley, J., Johns Hopkins Molecular Tumor Board Investigators, Canzoniero, J., and Grossman, S.A. (2023). Druggable Genomic Landscapes of High-Grade Gliomas. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1254955"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00432-022-04050-w","article-title":"Precision Neuro-Oncology: A Pilot Analysis of Personalized Treatment in Recurrent Glioma","volume":"149","author":"Lazaridis","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"113339","DOI":"10.1016\/j.celrep.2023.113339","article-title":"Targeting the Non-Coding Genome and Temozolomide Signature Enables CRISPR-Mediated Glioma Oncolysis","volume":"42","author":"Tan","year":"2023","journal-title":"Cell Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s12967-023-04388-w","article-title":"Exploration of the Radiosensitivity-Related Prognostic Risk Signature in Patients with Glioma: Evidence from Microarray Data","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/jrr\/rrad053","article-title":"Expression of TMEM59L Associated with Radiosensitive in Glioblastoma","volume":"64","author":"Gao","year":"2023","journal-title":"J. Radiat. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13014-023-02385-3","article-title":"Histopathologically Confirmed Radiation-Induced Damage of the Brain\u2014An in-Depth Analysis of Radiation Parameters and Spatio-Temporal Occurrence","volume":"18","author":"Kossmann","year":"2023","journal-title":"Radiat. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"CASE23361","DOI":"10.3171\/CASE23361","article-title":"Clinical, Imaging, and Molecular Features of Radiation-Induced Glioblastomas Developing More than 20 Years After Radiation Therapy for Intracranial Germinomatous Germ Cell Tumor: Illustrative Cases","volume":"6","author":"Tsukamoto","year":"2023","journal-title":"J. Neurosurg. Case Lessons"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00701-023-05637-z","article-title":"Epithelioid Glioblastoma Diagnosed 70 Years After Craniofacial Radiotherapy","volume":"165","author":"Bugdadi","year":"2023","journal-title":"Acta Neurochir."},{"key":"ref_47","first-page":"100658","article-title":"Risk of Stroke-Specific Mortality After Radiotherapy in Patients with Primary Brain Tumours","volume":"42","author":"Kouli","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14791\/btrt.2023.0004","article-title":"Factors Associated with Neurocognitive Impairment Following Chemoradiotherapy in Patients with High-Grade Glioma: Results of a Prospective Trial","volume":"11","author":"Sharma","year":"2023","journal-title":"Brain Tumor. Res. Treat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11060-023-04533-x","article-title":"Neuropsychological Functioning during Chemotherapy with Temozolomide in High-Grade Glioma Patients: A Retrospective Single Centre Study","volume":"165","author":"Fanizzi","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-023-04419-y","article-title":"Long-Term Neurocognitive Function and Quality of Life After Multimodal Therapy in Adult Glioma Patients: A Pro-spective Long-Term Follow-Up","volume":"164","author":"Pertz","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100451","DOI":"10.1016\/j.phro.2023.100451","article-title":"Radiation-Dependent Demyelination in Normal Appearing White Matter in Glioma Patients, Determined using Quantitative Magnetic Resonance Imaging","volume":"27","author":"Ljusberg","year":"2023","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/neuonc\/noad064","article-title":"ATM Inhibition Enhances the Efficacy of Radiation Across Distinct Molecular Subgroups of Pediatric High-Grade Glioma","volume":"25","author":"Xie","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/1535-7163.MCT-23-0026","article-title":"Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence","volume":"23","author":"Sharma","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e3760","DOI":"10.1002\/cnm.3760","article-title":"Effects of Tumour Heterogeneous Properties on Modelling the Transport of Radiative Particles","volume":"39","author":"Juma","year":"2023","journal-title":"Int. J. Numer. Method Biomed. Eng."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00066-023-02057-x","article-title":"Second Course of Re-Irradiation in Pediatric Diffuse Intrinsic Pontine Glioma: A Case Study","volume":"199","author":"Bergengruen","year":"2023","journal-title":"Strahlenther. Onkol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lo Greco, M.C., Milazzotto, R., Liardo, R.L.E., Foti, P.V., Palmucci, S., Basile, A., Pergolizzi, S., and Spatola, C. (2023). The Role of Reirradiation in Childhood Progressive Diffuse Intrinsic Pontine Glioma (DIPG): An Ongoing Challenge Beyond Radiobiology. Brain Sci., 13.","DOI":"10.3390\/brainsci13101449"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"De Saint-Hubert, M., Boissonnat, G., Schneider, U., B\u00e4umer, C., Verbeek, N., Esser, J., Wulff, J., Stuckmann, F., Suesselbeck, F., and Nabha, R. (2023). Complete Patient Exposure during Paediatric Brain Cancer Treatment for Photon and Proton Therapy Techniques In-cluding Imaging Procedures. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1222800"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ijrobp.2023.01.016","article-title":"Conformal Radiation Therapy for Ependymoma at Age \u22643 Years: A 25-Year Experience","volume":"116","author":"Howe","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clon.2023.05.007","article-title":"Re-Irradiation in Paediatric Tumours of the Central Nervous System: National Guidelines from the Swedish Workgroup of Paediatric Radiotherapy","volume":"35","author":"Embring","year":"2023","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"CASE23346","DOI":"10.3171\/CASE23346","article-title":"Novel Combination of GammaTile Cesium-131 Brachytherapy with 5-Aminolevulinic Acid Fluorescence-Guided Resection in the Re-Irradiation of Pediatric Recurrent High-Grade Glioma: Illustrative Case","volume":"6","author":"Gordon","year":"2023","journal-title":"J. Neurosurg. Case Lessons"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e30751","DOI":"10.1002\/pbc.30751","article-title":"The Impact of Radiation Therapy Variables on Pediatric High-Grade Glioma Outcomes: A National Cancer Database Analysis","volume":"71","author":"Williamson","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/MPH.0000000000002792","article-title":"Bevacizumab in the Treatment of Refractory Brain Edema in High-Grade Glioma","volume":"46","author":"Alsahlawi","year":"2024","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/09297049.2022.2144189","article-title":"Formula: See Text] the Neuropsychological Profile of Children with Diffuse Intrinsic Pontine Glioma (DIPG) before and After Radiation Therapy: A Prospective Longitudinal Study","volume":"29","author":"Rhodes","year":"2023","journal-title":"Child. Neuropsychol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"175537","DOI":"10.1016\/j.ejphar.2023.175537","article-title":"Natural and Synthetic Compounds for Glioma Treatment Based on ROS-Mediated Strategy","volume":"953","author":"Wang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"215172","DOI":"10.1016\/j.ccr.2023.215172","article-title":"Vector Enabled CRISPR Gene Editing\u2014A Revolutionary Strategy for Targeting the Diversity of Brain Pathologies","volume":"487","author":"Forgham","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wu, D., Chen, X., Zhou, S., and Li, B. (2023). Reactive Oxidative Species (ROS)-Based Nanomedicine for BBB Crossing and Glioma Treatment: Current Status and Future Directions. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1241791"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10528-023-10479-6","article-title":"Long Non-Coding RNA Prader Willi\/Angelman Region RNA 6 Suppresses Glioma Development by Modulating MicroRNA-106a-5p","volume":"62","author":"E","year":"2023","journal-title":"Biochem. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhang, L., Zhang, Y., Li, K., and Xue, S. (2023). Hedgehog Signaling and the Glioma-Associated Oncogene in Cancer Radioresistance. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1257173"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","article-title":"The Evolving Role of Reirradiation in the Management of Recurrent Brain Tumors","volume":"164","author":"Zaccaro","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-023-04466-5","article-title":"Preoperative Stereotactic Radiosurgery as Neoadjuvant Therapy for Resectable Brain Tumors","volume":"165","author":"Crompton","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-023-04398-0","article-title":"Phase II Study of Border Zone Stereotactic Radiosurgery with Bevacizumab in Patients with Recurrent Or Progressive Glioblastoma Multiforme","volume":"164","author":"Mantica","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00066-023-02118-1","article-title":"Prospective Randomized Clinical Studies Involving Reirradiation: Update of a Systematic Review","volume":"199","author":"Nieder","year":"2023","journal-title":"Strahlenther. Onkol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-023-04441-0","article-title":"Reirradiation Versus Systemic Therapy Versus Combination Therapy for Recurrent High-Grade Glioma: A Systematic Review and Meta-Analysis of Survival and Toxicity","volume":"164","author":"Marwah","year":"2023","journal-title":"J. Neurooncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e12910","DOI":"10.1111\/jpi.12910","article-title":"Primary Gamma Knife Radiosurgery for Pineal Region Tumors: A Systematic Review and Pooled Analysis of Available Literature with Histological Stratification","volume":"75","author":"Gagliardi","year":"2023","journal-title":"J. Pineal Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Le Reun, E., and Foray, N. (2023). Low-Dose Radiation Therapy (LDRT) Against Cancer and Inflammatory Or Degenerative Diseases: Three Parallel Sto-ries with a Common Molecular Mechanism Involving the Nucleoshuttling of the ATM Protein?. Cancers, 15.","DOI":"10.3390\/cancers15051482"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"101710","DOI":"10.1016\/j.tranon.2023.101710","article-title":"Low-Dose Radiotherapy Effects the Progression of Anti-Tumor Response","volume":"35","author":"Gao","year":"2023","journal-title":"Transl. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jnr.25030","article-title":"Improving Control of High-Grade Glioma by Ultra-Hyper-Fractionated Radiotherapy","volume":"100","author":"Frosina","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/cbdd.14311","article-title":"A Review of Recent Advancements in Actinium-225 Labeled Compounds and Biomolecules for Therapeutic Purposes","volume":"102","author":"Hassan","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"123747","DOI":"10.1016\/j.ijpharm.2023.123747","article-title":"Targeted Strategies to Deliver Boron Agents Across the Blood-Brain Barrier for Neutron Capture Therapy of Brain Tumors","volume":"650","author":"Lan","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Fujikawa, Y., Fukuo, Y., Nishimura, K., Tsujino, K., Kashiwagi, H., Hiramatsu, R., Nonoguchi, N., Furuse, M., Takami, T., and Hu, N. (2023). Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated Closo-Dodecaborate on a Rat Brain Tumor Model. Biology, 12.","DOI":"10.20944\/preprints202308.0638.v1"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"112946","DOI":"10.1016\/j.ejca.2023.112946","article-title":"Health-Related Quality-of-Life Results from the Randomised Phase II TAVAREC Trial on Temozolomide with Or without Bevacizumab in 1p\/19q Intact First-Recurrence World Health Organization Grade 2 and 3 Glioma (European Organization for Research and Treatment of Cancer 26091)","volume":"190","author":"Reijneveld","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cecchi, N., Romanelli, R., Ricevuti, F., Amitrano, M., Carbone, M.G., Dinardo, M., and Burgio, E. (2023). Current Knowledges in Pharmaconutrition: \u201cKetogenics\u201d in Pediatric Gliomas. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1222908"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Hung, K., Sun, C., Chang, Y., Wu, J., Huang, P., Liu, T., Lin, C., Cheng, W., and Chen, I. (2023). Association of Prognostic Nutritional Index with Prognostic Outcomes in Patients with Glioma: A Meta-Analysis and Systematic Review. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1188292"},{"key":"ref_84","first-page":"446","article-title":"Does the Distance to the Cancer Center Affect Psycho-Oncological Care and Emergency Visits of Patients with IDH Wild-Type Gliomas? A Retrospective Study","volume":"10","author":"Fischl","year":"2023","journal-title":"Neurooncol. Pract."},{"key":"ref_85","first-page":"381","article-title":"Brain and Other Central Nervous System Tumor Statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/neuonc\/noad105","article-title":"PNOC015: Repeated Convection-Enhanced Delivery of MTX110 (Aqueous Panobinostat) in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma","volume":"25","author":"Mueller","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/djad190","article-title":"Evolving Therapies, Neurocognitive Outcomes and Functional Independence in Adult Survivors of Childhood Glioma","volume":"116","author":"Papini","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00117-023-01170-3","article-title":"Secondary Tumors Following Radiation Therapy and Chemotherapy: Incidence of Cavernous Hemangiomas","volume":"63","author":"Reith","year":"2023","journal-title":"Radiologie"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00432-025-06171-4","article-title":"Limited Survival Benefit in Patients Diagnosed with Glioblastoma Post-2016: A SEER Population Based Registry Analysis","volume":"151","author":"Dhingra","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Wen, Z., Liu, J., Bai, Y., Zhou, M., He, J., Xu, Y., Yan, Y., Li, F., Gong, S., and Li, J. (2025). Efficacy and Safety of Low-Dose X-Rays Based Intraoperative Radiotherapy for High-Grade Gliomas: A Single-Center Retrospective Study. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1548276"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10143-024-02279-2","article-title":"Efficacy and Safety of Intraoperative Radiotherapy for High-Grade Gliomas: A Systematic Review and Meta-Analysis","volume":"47","author":"Palavani","year":"2024","journal-title":"Neurosurg. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Yu, V.Y., Nguyen, D., O\u2019Connor, D., Ruan, D., Kaprealian, T., Chin, R., and Sheng, K. (2021). Treating Glioblastoma Multiforme (GBM) with Super Hyperfractionated Radiation Therapy: Implication of Temporal Dose Fractionation Optimization Including Cancer Stem Cell Dynamics. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245676"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/ijc.34801","article-title":"Low-Dose Radiation Therapy Mobilizes Antitumor Immunity: New Findings and Future Perspectives","volume":"154","author":"Zhou","year":"2024","journal-title":"Int. J. Cancer"},{"key":"ref_94","unstructured":"Lin, T., Ke, S., Hu, C., Assadi, R., Huang, J., Gupta, S., Rawojc, K., Kleinberg, L., Mukherjee, D., and Rincon-Torroella, J. Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Temozolomide for Recurrent Anaplastic Astrocy-toma and Glioblastoma: A Single-Arm Phase I\/II Trial. Int. J. Radiat. Oncol. Biol. Phys., Online ahead of print."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/jnr.24929","article-title":"Ultra-Hyper-Fractionated Radiotherapy for High-Grade Gliomas","volume":"99","author":"Frosina","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab Plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00066-013-0506-z","article-title":"Low-Dose Fractionated Radiotherapy and Concomitant Chemotherapy for Recurrent Or Progressive Glioblastoma: Final Report of a Pilot Study","volume":"190","author":"Balducci","year":"2014","journal-title":"Strahlenther. Onkol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"109768","DOI":"10.1016\/j.radonc.2023.109768","article-title":"Dosimetric Patterns of Failure in the Era of Novel Chemoradiotherapy in Newly-Diagnosed Glioblastoma Patients","volume":"188","author":"Seaberg","year":"2023","journal-title":"Radiother. Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10143-023-02126-w","article-title":"Butterfly Gliomas: A Time for Stratified Management?","volume":"46","author":"Sinha","year":"2023","journal-title":"Neurosurg. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/662\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:25:44Z","timestamp":1767950744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":100,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27020662"],"URL":"https:\/\/doi.org\/10.3390\/ijms27020662","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}